-
Samsung Biologics Expands Vaccine Manufacturing Capabilities
contractpharma
June 02, 2021
Samsung Biologics, a global CDMO providing end-to-end contract development and manufacturing services, unveiled plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility in Songdo, ready for cGMP operations within ...
-
MedPharm Opens New Manufacturing Facility
contractpharma
June 02, 2021
State-of-the-art facility in Durham, NC expands the CDMO’s topical and transdermal delivery capabilities.
-
Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services
prnasia
June 01, 2021
Samsung Biologics announced its plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility in Songdo, ready for cGMP operations within the earlier part of the year in 2022.
-
Trends to watch out for in the pharmaceutical robot market
europeanpharmaceuticalreview
April 26, 2021
EPR’s Hannah Balfour summarises a market research report exploring trends in the pharmaceutical robot market between 2021 and 2028.
-
Catalent Biologics Completes Madison Expansion
contractpharma
April 14, 2021
Catalent has completed the expansion of two new suites at its biologics drug substance development and manufacturing facility in Madison, WI, and began work on customer programs.
-
Sanofi Invests in Cutting Edge Vax Production Site in Singapore
contractpharma
April 13, 2021
The factory will house several fully digitalized modules that allow production of three to four vaccines simultaneously.
-
Steriline Delivers New Manufacturing Line to Bess Pro
contractpharma
April 01, 2021
Steriline, a highly specialized manufacturer of complete lines for the aseptic processing of injectable drugs, has successfully delivered a new line to bess pro gmbh, a Berlin located company part of the bess group, manufacturing and distributing ...
-
Thermo Fisher Scientific Further Expands Global Footprint
contractpharma
December 11, 2020
Thermo Fisher Scientific will further expand its footprint in North America and Europe for sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines.
-
Career prospects in pharma in the new normal
expresspharma
December 07, 2020
The manpower needs in the pharma industry are foremost in manufacturing, quality assurance, quality control and sales, followed by other functions like HR, IT, and marketing. In this article, we’ll focus on career prospects in the top key domains of ...
-
Lonza Expands HPAPI Capabilities
contractpharma
November 20, 2020
Lonza has made additional investments in its oral drug product development and manufacturing capabilities at its Tampa, FL site. Capability for formulation development has been enhanced with the upgrade of drug product development laboratories for ...